The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies

키워드

참고문헌 (94)

1. O’Neill S, "Metabolic syndrome : a closer look at the growing epidemic and its associated pathologies", Obes Rev, 16, pp.1~12 (2015)
2. Helen H. Wang, "Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome", Pediatric Gastroenterology, Hepatology & Nutrition, 23(3), pp.189~230 (2020), 대한소아소화기영양학회[DOI]
3. Engin A, "The definition and prevalence of obesity and metabolic syndrome", Adv Exp Med Biol, 960, pp.1~17 (2017)
4. Gierach M, "Correlation between body mass index and waist circumference in patients with metabolic syndrome", ISRN Endocrinol, 2014, pp.514589~ (2014)
5. Ansarimoghaddam A, "Prevalence of metabolic syndrome in Middle-East countries : meta-analysis of cross-sectional studies", Diabetes Metab Syndr, 12, pp.195~201 (2018)
6. Pucci G, "Sex-and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome : a review of the literature", Pharmacol Res, 120, pp.34~42 (2017)
7. Montella M, "Metabolic syndrome and the risk of urothelial carcinoma of the bladder : a case-control study", BMC Cancer, 15, pp.720~ (2015)
8. Cantiello F, "Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer : a systematic review", Int J Urol, 22, pp.22~32 (2015)
9. Esposito K, "Metabolic syndrome and cancer: holistic or reductionist?", Endocrine, 45, pp.362~364 (2014)
10. Rosato V, "Metabolic syndrome and endometrial cancer risk", Ann Oncol, 22, pp.884~889 (2011)
11. Watanabe J, "Metabolic syndrome is a risk factor for cancer mortality in the general Japanese population : the Jichi Medical School Cohort Study", Diabetol Metab Syndr, 11, pp.3~ (2019)
12. Ozbek E, "Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder", Asian Pac J Cancer Prev, 15, pp.1447~1451 (2014)
13. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
14. Johansson SL, "Epidemiology and etiology of bladder cancer", Semin Surg Oncol, 13, pp.291~298 (1997)
15. Saginala K, "Epidemiology of bladder cancer", Med Sci(Basel), 8, pp.15~ (2020)
16. Garg T, "Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults", Urol Oncol, 38, pp.737.e17~737.e23 (2020)
17. Nagase K, "The association between metabolic syndrome and high-stage primary urothelial carcinoma of the bladder", Curr Urol, 12, pp.39~42 (2018)
18. Lotan Y, "Metabolic syndrome and bladder cancer", BJU Int, 128, pp.1~2 (2021)
19. Häggström C, "Metabolic syndrome and risk of bladder cancer : prospective cohort study in the metabolic syndrome and cancer project(Me-Can)", Int J Cancer, 128, pp.1890~1898 (2011)
20. Swerdlow AJ, "Cancer incidence and mortality in patients with insulin-treated diabetes : a UK cohort study", Br J Cancer, 92, pp.2070~2075 (2005)
21. Larsson SC, "Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men", Eur J Cancer, 44, pp.2655~2660 (2008)
22. Woolcott CG, "Diabetes and urothelial cancer risk : the Multiethnic Cohort study", Cancer Epidemiol, 35, pp.551~554 (2011)
23. Koebnick C, "Body mass index, physical activity, and bladder cancer in a large prospective study", Cancer Epidemiol Biomarkers Prev, 17, pp.1214~1221 (2008)
24. Peng XF, "The association between metabolic syndrome and bladder cancer susceptibility and prognosis : an updated comprehensive evidence synthesis of 95 observational studies involving 97, 795, 299 subjects", Cancer Manag Res, 10, pp.6263~6274 (2018)
25. Peterson J, "The Newcastle-Ottawa scale(NOS)for assessing the quality of nonrandomised studies in meta-analyses", pp.1~12 (2011), Ottawa Hospital Research Institute
26. Yood MU, "Incidence of cancer in a population-based cohort of patients with type 2 diabetes", Diabetes Metab Syndr Clin Res Rev, 3, pp.12~16 (2009)
27. Woolcott CG, "Diabetes and urothelial cancer risk : the Multiethnic Cohort study", Cancer Epidemiol, 35, pp.551~554 (2011)
28. Tripathi A, "Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women’s Health Study", Cancer, 95, pp.2316~2323 (2002)
29. Prizment AE, "Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study", Cancer Causes Control, 24, pp.603~608 (2013)
30. Newton CC, "Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study", Int J Cancer, 132, pp.2186~2191 (2013)
31. Lai GY, "The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study", J Clin Endocrinol Metab, 98, pp.E497~E502 (2013)
32. Holick CN, "Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women", Int J Cancer, 120, pp.140~146 (2007)
33. Cantwell MM, "Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study", Int J Cancer, 119, pp.2398~2401 (2006)
34. Atchison EA, "Risk of cancer in a large cohort of U. S. veterans with diabetes", Int J Cancer, 128, pp.635~643 (2011)
35. Andreotti G, "Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort", Cancer Causes Control, 21, pp.1759~1775 (2010)
36. Wolk A, "A prospective study of obesity and cancer risk(Sweden)", Cancer Causes Control, 12, pp.13~21 (2001)
37. Teleka S, "Association between blood pressure and BMI with bladder cancer risk and mortality in 340, 000 men in three Swedish cohorts", Cancer Med, 10, pp.1431~1438 (2021)
38. Stocks T, "Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project", Hypertension, 59, pp.802~810 (2012)
39. Samanic C, "Relation of body mass index to cancer risk in 362, 552 Swedish men", Cancer Causes Control, 17, pp.901~909 (2006)
40. Lukanova A, "Body mass index and cancer : results from the Northern Sweden Health and Disease Cohort", Int J Cancer, 118, pp.458~466 (2006)
41. Hemminki K, "Risk of cancer following hospitalization for type 2 diabetes", Oncologist, 15, pp.548~555 (2010)
42. Bae WJ, "Influence of diabetes on the risk of urothelial cancer according to body mass index : a 10-year nationwide population-based observational study", J Cancer, 9, pp.488~493 (2018)
43. Choi JB, "Association of body mass index with bladder cancer risk in men depends on abdominal obesity", World J Urol, 37, pp.2393~2400 (2019)
44. Jee SH, "Body mass index and cancer risk in Korean men and women", Int J Cancer, 123, pp.1892~1896 (2008)
45. Kim JW, "Increased incidence of bladder cancer with metabolically unhealthy status : analysis from the National Health Checkup database in Korea", Sci Rep, 10, pp.6476~ (2020)
46. Suk Kyeong Kim, "Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea", The Korean Journal of Internal Medicine, 35(3), pp.641~651 (2020), 대한내과학회[DOI]
47. Ko SH, "Impact of obesity and diabetes on the incidence of kidney and bladder cancers : a nationwide cohort study", Eur J Endocrinol, 181, pp.489~498 (2019)
48. Kwon T, "Obesity and prognosis in muscle-invasive bladder cancer : the continuing controversy", Int J Urol, 21, pp.1106~1112 (2014)
49. Oh SW, "Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men : Korea National Health Insurance Corporation Study", J Clin Oncol, 23, pp.4742~4754 (2005)
50. Bhaskaran K, "Body-mass index and risk of 22 specific cancers : a population-based cohort study of 5·24 million UK adults", Lancet, 384, pp.755~765 (2014)
51. Cao Z, "Association of obesity status and metabolic syndrome with site-specific cancers : a population-based cohort study", Br J Cancer, 123, pp.1336~1344 (2020)
52. Goossens ME, "Risk of bladder cancer in patients with diabetes : a retrospective cohort study", BMJ Open, 5, pp.e007470~ (2015)
53. Peila R, "Diabetes, glycated hemoglobin, and risk of cancer in the UK Biobank study", Cancer Epidemiol Biomarkers Prev, 29, pp.1107~1119 (2020)
54. Reeves GK, "Cancer incidence and mortality in relation to body mass index in the Million Women Study : cohort study", BMJ, 335, pp.1134~ (2007)
55. Chen HF, "Risk of malignant neoplasms of kidney and bladder in a cohort study of the diabetic population in taiwan with age, sex, and geographic area stratifications", Medicine(Baltimore), 94, pp.e1494~ (2015)
56. Tseng CH, "Diabetes and risk of bladder cancer : a study using the National Health Insurance database in Taiwan", Diabetologia, 54, pp.2009~2015 (2011)
57. Lo SF, "Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients", Int J Cancer, 132, pp.182~188 (2013)
58. Lin CC, "Cancer risks among patients with type 2 diabetes : a 10-year follow-up study of a nationwide population-based cohort in Taiwan", BMC Cancer, 14, pp.381~ (2014)
59. Lee HY, "The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database", Int J Clin Oncol, 26, pp.569~577 (2021)
60. Kok VC, "Positive association between hypertension and urinary bladder cancer : epidemiologic evidence involving 79, 236 propensity score-matched individuals", Ups J Med Sci, 123, pp.109~115 (2018)
61. Huang WL, "Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer : a retrospective study", BMC Urol, 20, pp.117~ (2020)
62. Xu HL, "Cancer incidence in patients with type 2 diabetes mellitus : a population-based cohort study in Shanghai", BMC Cancer, 15, pp.852~ (2015)
63. Xu T, "Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer", Int Urol Nephrol, 47, pp.1135~1141 (2015)
64. Inoue M, "Diabetes mellitus and the risk of cancer : results from a large-scale population-based cohort study in Japan", Arch Intern Med, 166, pp.1871~1877 (2006)
65. Khan M, "Site-specific cancer risk due to diabetes mellitus history : evidence from the Japan Collaborative Cohort(JACC)Study", Asian Pac J Cancer Prev, 7, pp.253~259 (2006)
66. Ballotari P, "Diabetes and risk of cancer incidence : results from a population-based cohort study in northern Italy", BMC Cancer, 17, pp.703~ (2017)
67. Russo A, "Metabolic syndrome and cancer risk", Eur J Cancer, 44, pp.293~297 (2008)
68. Ogunleye AA, "A cohort study of the risk of cancer associated with type 2 diabetes", Br J Cancer, 101, pp.1199~1201 (2009)
69. Walker JJ, "Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007", Diabetologia, 56, pp.1712~1725 (2013)
70. Rapp K, "Obesity and incidence of cancer : a large cohort study of over 145, 000 adults in Austria", Br J Cancer, 93, pp.1062~1067 (2005)
71. Rapp K, "Fasting blood glucose and cancer risk in a cohort of more than 140, 000 adults in Austria", Diabetologia, 49, pp.945~952 (2006)
72. Rastad H, "Diabetes mellitus and cancer incidence : the Atherosclerosis Risk in Communities(ARIC)cohort study", J Diabetes Metab Disord, 18, pp.65~72 (2019)
73. Hektoen HH, "Lifestyle associated factors and risk of urinary bladder cancer : a prospective cohort study from Norway", Cancer Med, 9, pp.4420~4432 (2020)
74. Evers J, "No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression", PLoS One, 15, pp.e0229384~ (2020)
75. Colmers IN, "Detection bias and overestimation of bladder cancer risk in type 2 diabetes : a matched cohort study", Diabetes Care, 36, pp.3070~3075 (2013)
76. Jee SH, "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293, pp.194~202 (2005)
77. Roswall N, "Anthropometric measures and bladder cancer risk : a prospective study in the EPIC cohort", Int J Cancer, 135, pp.2918~2929 (2014)
78. Esposito K, "Metabolic syndrome and risk of cancer : a systematic review and meta-analysis", Diabetes Care, 35, pp.2402~2411 (2012)
79. Trabert B, "Metabolic syndrome and risk of endometrial cancer in the United States : a study in the SEER-medicare linked database", Cancer Epidemiol Biomarkers Prev, 24, pp.261~267 (2015)
80. Cumberbatch MG, "Epidemiology of bladder cancer : a systematic review and contemporary update of risk factors in 2018", Eur Urol, 74, pp.784~795 (2018)
81. Teleka S, "Risk of bladder cancer by disease severity in relation to metabolic factors and smoking : a prospective pooled cohort study of 800, 000 men and women", Int J Cancer, 143, pp.3071~3082 (2018)
82. Chen SL, "Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models", J Urol, 182(6 Suppl), pp.S51~S56 (2009)
83. Zhao H, "Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk", J Urol, 169, pp.714~717 (2003)
84. La Vecchia C, "Genital and urinary tract diseases and bladder cancer", Cancer Res, 51, pp.629~631 (1991)
85. Jiang X, "Water intake and bladder cancer risk in Los Angeles County", Int J Cancer, 123, pp.1649~1656 (2008)
86. Michaud DS, "Chronic inflammation and bladder cancer", Urol Oncol, 25, pp.260~268 (2007)
87. Brown JS, "Urologic complications of diabetes", Diabetes Care, 28, pp.177~185 (2005)
88. "Obesity: preventing and managing the global epidemic: report of a WHO consultation" (2020)[URL]
89. Jiang X, "Hypertension, diuretics and antihypertensives in relation to bladder cancer", Carcinogenesis, 31, pp.1964~1971 (2010)
90. Sun LM, "Hypertension and subsequent genitourinary and gynecologic cancers risk: a population-based cohort study", Medicine(Baltimore), 94, pp.e753~ (2015)
91. Hole DJ, "Incidence of and mortality from cancer in hypertensive patients", BMJ, 306, pp.609~611 (1993)
92. Koene RJ, "Shared risk factors in cardiovascular disease and cancer", Circulation, 133, pp.1104~1114 (2016)
93. Radišauskas R, "Hypertension, serum lipids and cancer risk: a review of epidemiological evidence", Medicina(Kaunas), 52, pp.89~98 (2016)
94. Montezano AC, "Molecular mechanisms of hypertension--reactive oxygen species and antioxidants : a basic science update for the clinician", Can J Cardiol, 28, pp.288~295 (2012)

관련 논문AI추천